Top Markets
#1 Helium Helium +83.36%
#2 Seeker Seeker +52.14%
#3 Pons Pons +36.63%
#4 UnifAI Network UnifAI Network +29.95%
#5 TENDIES TENDIES +27.32%
#6 Tensor Tensor +23.80%
#7 Zylo Ecosystem Zylo Ecosystem +23.78%
#8 Bounce Bounce +17.72%
#9 pipedog pipedog +16.96%
#10 Songbird Songbird +15.11%
Coin of the day
Helium Helium
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Climb Bio, Inc. Climb Bio, Inc.

Climb Bio, Inc.

CLYM
Peringkat dalam Saham #10440
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic... Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.
Harga Saham
$14.66
Terakhir disinkronkan: 2026-08-28
Kapitalisasi Pasar
$839.37M
Perubahan (1 hari)
-2.67%
Perubahan (1 tahun)
557.32%
Negara
US
Perdagangan Climb Bio, Inc. (CLYM)

Kategori

Healthcare
Rasio P/S untuk Climb Bio, Inc. (CLYM)
Rasio P/S per 2026 TTM: 0
Menurut laporan keuangan dan harga saham terbaru dari Climb Bio, Inc., rasio P/S saat ini (TTM) adalah 0. Pada akhir 2026, rasio P/S perusahaan adalah 0.
Riwayat rasio P/S untuk Climb Bio, Inc. dari 2026 hingga 2026
Rasio P/S pada akhir setiap tahun
Tahun Rasio P/S Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Rasio P/S untuk perusahaan sejenis atau pesaing
Perusahaan Rasio P/S Perbedaan Rasio P/S Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH